Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of HBOC-201 (Hemopure) for Wound Healing After Lower Limb Amputation in Critical Limb Ischemia
2005-003637-41Phase 2Completed
- Sponsor
- Biopure
- Start
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in arteriosclerosis obliterans and chronic limb-threatening ischemia (CLTI) comparing HBOC-201 (Hemopure) with Placebo (2 arms). Started Oct 2005; status: completed.
02
Drugs
hemoglobin glutamer-250
03
Conditions
arteriosclerosis obliteranschronic limb-threatening ischemia (CLTI)
Beyond the preview
Go deeper on 2005-003637-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003637-41.